Dr. Annette Marie Esper, MD

Dr. Esper practices at Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority.

Dr. Esper's NPI, 1285661389, was assigned on June 26, 2006. Dr. Esper holds Georgia license 054776.

Dr. Esper's primary practice is Grady Memorial Hospital, at 80 Jesse Hill, Jr Drive SE, Atlanta, GA 30303 in Fulton County. The practice phone is (404) 616-1000.

Dr. Esper's primary practice is Grady Memorial Hospital in Atlanta, Georgia, part of The Fulton-DeKalb Hospital Authority. Dr. Esper is also affiliated with Emory Hillandale Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Esper to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Esper practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Esper's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Esper is licensed in Georgia.

CMS data shows 11 Medicare services from Dr. Esper across 1 procedure code in 2023, all of them office visits, for 29 Medicare patients. Medicare paid $424 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 29 Medicare patients who saw Dr. Esper in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Esper's median patient age at 68, with 59% women.

In 2024, Dr. Esper wrote 1,417 Medicare Part D claims for 262 patients. 35% of them were for generic drugs. CMS names the drug for 1,295 of them, across 28 drugs with 11 or more claims each, at $305,515 in total drug cost. In 2023, CMS named 1,563 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Esper for performance year 2024, reported as part of a group. Dr. Esper accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Esper, published from 2009 to 2024. 2022 was the busiest year, with 8. The most frequent topics are COVID-19, Critical Illness and SARS-CoV-2. Dr. Esper has published most often in Crit Care Med. Dr. Esper's most frequent co-authors are Andre Lavar Holder, MD, Russell Ryan Kempker, MD and Robert A. Balk, MD.

Dmand AI links Dr. Esper to 1 clinical trial. Conditions studied include Acute Lung Injury and Lung Injury.

CMS Open Payments shows 3 general payments to Dr. Esper from 3 drug and device companies from 2016 to 2020. Honoraria make up the largest share, 99% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $2,300.